% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • system_architect_enterprise system_architect_enterprise Feb 1, 2013 7:06 AM Flag

    Juxtapid 2x as effective as Kynamro

    Wall Street Journal article yesterday pointed out that Juxtapid lowered cholesterol by half in 26 weeks versus Kynamro that only reduced cholesterol 25% over the same 26 weeks.

    They also cited Kynamro trying to offset their ineffectiveness with a lower price tag of $176,000 versus $235,000-295,000, though if you are dying and already paying a high price for meds, you probably are going to go for the most effective treatment you can. Especially considering Kynamro's links to causing cancer versus Juxtapid's clean safety profile.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.03+0.02(+1.00%)11:25 AMEDT